NO177310C -
HBxAg antigenic polypeptide, antibody that reacts with the polypeptide, diagnostic assay system to determine the presence of HBxAg in a body sample, and use of the polypeptide for in vitro diagnosis
- Google Patents
HBxAg antigenic polypeptide, antibody that reacts with the polypeptide, diagnostic assay system to determine the presence of HBxAg in a body sample, and use of the polypeptide for in vitro diagnosis
Info
Publication number
NO177310C
NO177310CNO890314ANO890314ANO177310CNO 177310 CNO177310 CNO 177310CNO 890314 ANO890314 ANO 890314ANO 890314 ANO890314 ANO 890314ANO 177310 CNO177310 CNO 177310C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/054,424external-prioritypatent/US4942125A/en
Application filed by Scripps Clinic ResfiledCriticalScripps Clinic Res
Publication of NO890314LpublicationCriticalpatent/NO890314L/en
Publication of NO890314D0publicationCriticalpatent/NO890314D0/en
Publication of NO177310BpublicationCriticalpatent/NO177310B/en
Publication of NO177310CpublicationCriticalpatent/NO177310C/en
NO890314A1987-05-261989-01-25
HBxAg antigenic polypeptide, antibody that reacts with the polypeptide, diagnostic assay system to determine the presence of HBxAg in a body sample, and use of the polypeptide for in vitro diagnosis
NO177310C
(en)
HBxAg antigenic polypeptide, antibody that reacts with the polypeptide, diagnostic assay system to determine the presence of HBxAg in a body sample, and use of the polypeptide for in vitro diagnosis
HBxAg antigenic polypeptide, antibody that reacts with the polypeptide, diagnostic assay system to determine the presence of HBxAg in a body sample, and use of the polypeptide for in vitro diagnosis
Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies.
METHODS FOR DIAGNOSIS IN VITRO OF HUMAN CYTOMEGALOVIRUS INFECTIONS AND USE OF MONOCLONAL ANTIBODIES TO CYTOMEGALOVIRUS REACTIVE WITH A CYTOMEGALOVIRUS-INDUCED PROTEIN KINASE.